viability was measured by considering the mitochondrial
function using Cell Counting Kit-8 (CCK8),14 and this result
indicates the possibility of using TBPCA for bioimaging live
cells in aqueous media.15
This work was supported by the KRF (Grant No. KRF-
2006-312-C00592), Seoul R&BD, the KOSEF, and the WCU
program through the KOSEF funded by the Korean Ministry
of Education, Science, and Technology (MEST). S. Y. K., J. P.
and M. K. are grateful for the fellowship award of the BK 21
Program and the Seoul Science Fellowship. We would like to
thank Dong-Seon Lee and Sangyun Lee for helpful
discussions regarding calculations.
TBPCA fulfills the requirements for displaying fluorescence
in in vitro cell imaging: it can be retained in a cell, it is non-
cytotoxic, and it can exhibit fluorescence upon sensing the
appropriate physiological conditions. On the basis of these
properties of TBPCA, which indicate that this probe is a
selective chemodosimeter for fluoride anions, we explored
the possibility of its use in biological systems by its application
to A549 human lung carcinoma cell lines. The addition of
50 mM NaF to A549 cells loaded with TBPCA (20 mM) leads
to a significant increase in the fluorescence intensity as
compared to control experiments (Fig. 3(b) and (c)). Due to
the slow rate of this reaction, the TBPCA-loaded A549 cells
with NaF have to be incubated for 3 h at 37 1C to obtain the
maximum fluorescence intensity; incubation for more than 3 h
causes the deterioration of the fluorescence signal.
Notes and references
1 (a) K. L. Kirk, Biochemistry of the Halogens and Inorganic Halides,
Plenum Press, New York, 1991, p. 58; (b) H. S. Horowitz, J. Public
Health Dent., 2003, 63, 3–8.
2 (a) B. L. Riggs, Bone and Mineral Research, Annual 2, Elsevier,
Amsterdam, 1984, pp. 366–393; (b) J. R. Farley, J. E. Wergedal
and D. J. Baylink, Science, 1983, 222, 330–332; (c) M. Kleerekoper,
Endocrinol. Metab. Clin. North Am., 1998, 27, 441–452.
3 (a) A. Wiseman, Handbook of Experimental Pharmacology XX/2,
Springer-Verlag, Berlin, 1970, Part 2, pp. 48–97; (b) J. A. Weatherall,
Pharmacology of Fluorides. in Handbook of Experimental
Pharmacology XX/1, Springer-Verlag, Berlin, 1969, Part 1,
pp. 141–172; (c) R. H. Dreisbuch, Handbook of Poisoning, Lange
Medical Publishers, Los Altos, CA, 1980.
4 M. L. Cittanova, B. Lelongt and M. C. Verpont, Anesthesiology,
1996, 84, 428–435.
5 P. P. Singh, M. K. Barjatiya, S. Dhing, R. Bhatnagar, S. Kothari
and V. Dhar, Urol. Res., 2001, 29, 238–244.
6 (a) T.-J. Chen, T.-M. Chen, C.-H. Chen and Y.-K. Lai, J. Cell.
Biochem., 1998, 69, 221–231; (b) M. H. Arhima, O. P. Gulati and
S. C. Sharma, Phytother. Res., 2004, 18, 244–246.
7 (a) C. D. Anuradha, S. Kanno and S. Hirano, Arch. Toxicol., 2000,
74, 226–230; (b) M. Refsnes, P. E. Schwarze, J. A. Holme and
M. Lag, Hum. Exp. Toxicol., 2003, 22, 111–123; (c) M. Matsui,
M. Morimoto, K. Horimoto and Y. Nishimura, Toxicol. In vitro,
2007, 21, 1113–1120.
To take advantage of the chemodosimeter, TBPCA was also
used for the quantification of fluoride ions in the cells. After
3 h incubation of the A549 cells with NaF (50 mM) under the
physiological conditions, the cells were harvested and
thoroughly washed. The harvested cells were sonicated and
centrifuged for the preparation of cell lysate in PBS buffer.
The resulting lysate was treated with TBPCA (2 mM) for
4 h at 25 1C to quantify the fluoride ions in the cell lysates;
the quantification was performed on the basis of the
fluorescence intensity and a standard curve prepared with
NaF-doped cell lysates. This new quantification method
reveals that 1.86 ꢂ 10ꢁ2 pmol fluoride anion is present
in the cytoplasm per cell under physiological conditions
(Fig. S12, ESIw).
8 (a) C. B. Black, B. Andrioletti, A. C. Try, C. Ruiperez and
J. L. Sessler, J. Am. Chem. Soc., 1999, 121, 10438–10439;
(b) S. Yamaguchi, S. Akiyama and K. Tamao, J. Am. Chem. Soc.,
2000, 122, 6793–6794; (c) E. J. Cho, J. W. Moon, S. W. Ko, J. Y. Lee,
S. K. Kim, J. Yoon and K. C. Nam, J. Am. Chem. Soc., 2003, 125,
In conclusion, we have successfully developed TBPCA as a
fluoride ion probe for fluorescence cell bioimaging with desired
properties, such as the detaining of the fluorophore inside a
cell, non-cytotoxicity to mammalian cells, fluorescence upon
sensing, appreciable solubility in water, and stoichiometric
reaction with analytes. We also demonstrated fluorescence cell
bioimaging using TBPCA for the detection of NaF in A549
human epithelial lung cancer cells under physiological
conditions. Moreover, TBPCA can be utilized for the
quantification of fluoride ions in living systems.
12376–12377; (d) M. Va
´
R. M. Pedrido, A. M. Gonza
zquez, L. Fabbrizzi, A. Taglietti,
lez-Noya and M. R. Bermejo, Angew.
´
Chem., Int. Ed., 2004, 43, 1962–1965; (e) T.-H. Kim and T. M. Swager,
Angew. Chem., Int. Ed., 2003, 42, 4803–4806; (f) X. Jiang,
M. C. Vieweger, J. C. Bollinger, B. Dragnea and D. Lee, Org. Lett.,
2007, 9, 3579–3582; (g) X. Y. Liu, D. R. Bai and S. Wang, Angew.
Chem., Int. Ed., 2006, 45, 5475–5478; (h) T. W. Hudnall and
F. P. Gabbaı, Chem. Commun., 2008, 4596–4597.
¨
11978–11986; (b) S. Y. Kim and J.-I. Hong, Org. Lett., 2007, 9,
¨
9 (a) T. W. Hudnall and F. P. Gabbaı, J. Am. Chem. Soc., 2007, 129,
3109–3112; (c) C.-W. Chiu and F. P. Gabbaı, J. Am. Chem. Soc.,
¨
2006, 128, 14248–14249; (d) X.-F. Yang, Spectrochim. Acta, Part A,
2007, 67, 321–326; (e) A. B. Descalzo, D. Jime
´
D. Beltran, P. Amoros, M. D. Marcos, R. Martı
nez, J. E. Haskouri,
nez-Manez and
´
´
´
´
J. Soto, Chem. Commun., 2002, 562–563; (f) M. Cametti and
K. Rissanen, Chem. Commun., 2009, 2809–2829.
10 C. C. Woodroofe and S. J. Lippard, J. Am. Chem. Soc., 2003, 125,
11458–11459.
11 Protective Groups in Organic Synthesis, ed. T. W. Greene and
P. G. M. Wuts, Wiley, New York, 3rd edn, 1999, pp. 113–148.
12 Q. Zhu, M. Uttamchandani, D. Li, M. L. Lesaicherre and
S. Q. Yao, Org. Lett., 2003, 5, 1257–1260.
13 The ab initio calculation of the Si–O bond in two different solvent
systems (water and n-hexane) was done using the Material Studio
4.2s program and the water-accessible area of the Si–O bond was
calculated using Naccess (V2.1.1) with stable conformers of
TBMCA and TBPCA. See ESIw for detailed procedures.
14 T. Mosmann, J. Immunol. Methods, 1983, 65, 55–63.
15 J. Park, H. Y. Lee, M.-H. Cho and S. B. Park, Angew. Chem., Int.
Ed., 2007, 46, 2018–2022.
Fig. 3 Brightfield image and fluorescence cell images of A549, human
epithelial lung carcinoma. (a) Bright-field image of A549 cells incu-
bated with TBPCA (20 mM) for 30 min and subsequently incubated for
3 h at 37 1C. (b) Fluorescence image of A549 incubated with TBPCA
(20 mM) for 30 min and subsequently incubated without NaF for 3 h at
37 1C. (c) Fluorescence image of A549 cells incubated with TBPCA
(20 mM) for 30 min and subsequently treated with 50 mM NaF for 3 h
at 37 1C. The scale bar represents 20 mm.
ꢀc
This journal is The Royal Society of Chemistry 2009
Chem. Commun., 2009, 4735–4737 | 4737